Indiana Biosciences Research Institute


The Indiana Biosciences Research Institute is an American nonprofit research and technology organization serving the state of Indiana. The IBRI is the nation's first industry-led collaborative life sciences research institute. Their work focuses on targeting diabetes, metabolic disease, and poor nutrition.

History

In 2012, pharmaceutical executive John C. Lechleiter from Eli Lilly & Company initially proposed the IBRI. In 2013, Indiana governor Mike Pence announced the formation of the IBRI. Pence later worked with life sciences leaders to secure $25 million in startup funds from the state.
In 2015, the IBRI hired David Broecker as CEO. In late 2015, the Indianapolis City-County Council approved $75 million to build a technology park called 16 Tech. In 2016, the IBRI hired Rainer Fischer as Chief Scientific Officer. In 2017, Governor Eric Holcomb reaffirmed the commitment made by his predecessor Mike Pence.

Leadership

Appointees to the IBRI’s Board of Directors include:
Appointees to the IBRI’s Scientific Advisory Board include: